---
figid: PMC6995033__nihms-1538317-f0003
figtitle: Therapeutic intervention to improve vascular health, especially in patients
  on cancer therapeutics with an inhibitory effect on the VEGF signaling pathway
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC6995033
filename: nihms-1538317-f0003.jpg
figlink: pmc/articles/PMC6995033/figure/F3/
number: F3
caption: Therapeutic intervention to improve vascular health, especially in patients
  on cancer therapeutics with an inhibitory effect on the VEGF signaling pathway.
  From Touyz RM, Herrmann SMS, Herrmann J. Vascular toxicities with VEGF inhibitor
  therapies-focus on hypertension and arterial thrombotic events. J Am Soc Hypertens.
  2018;12(6):409–425; with permission.
papertitle: Common Vascular Toxicities of Cancer Therapies.
reftext: Joerg Herrmann. Cardiol Clin. ;37(4):365-384.
year: ''
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9576653
figid_alias: PMC6995033__F3
figtype: Figure
redirect_from: /figures/PMC6995033__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6995033__nihms-1538317-f0003.html
  '@type': Dataset
  description: Therapeutic intervention to improve vascular health, especially in
    patients on cancer therapeutics with an inhibitory effect on the VEGF signaling
    pathway. From Touyz RM, Herrmann SMS, Herrmann J. Vascular toxicities with VEGF
    inhibitor therapies-focus on hypertension and arterial thrombotic events. J Am
    Soc Hypertens. 2018;12(6):409–425; with permission.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Pvf1
  - Pvf2
  - Pvf3
  - Pvr
  - Fak
  - Fit1
  - norpA
  - sl
  - Plc21C
  - levy
  - COX6AL2
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - Akt
  - Erk7
  - rl
  - Gycalpha99B
  - Pkg21D
  - Ace
  - Acer
  - Ance
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - KDR
  - FLT1
  - FLT4
  - PTK2
  - IL1RL1
  - FITM1
  - HSPG2
  - PLCE1
  - PLCZ1
  - PLCB1
  - PLCB2
  - PLCB3
  - PLCB4
  - PLCD1
  - PLCD3
  - PLCD4
  - PLCG1
  - PLCG2
  - SEMA6A
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - EPHB2
  - MAPK1
  - MAPK3
  - NOS3
  - ENO4
  - EDN1
  - SGCB
  - GUCY1A2
  - GUCY1A1
  - GUCY1B1
  - GUCY1B2
  - ACE
  - Statins
  - Ponatinib
  - Nilotinib
  - Aspirin
  - NO H
  - CGMP
  - 'NO'
  - Amlodipine
  - platelet aggregation
  - hypertensives
  - Hypertension
---
